Off Label NCCN denied for missing prior authorization by Humana?

Humana's specific coverage criteria for off label nccn are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Required Prior Authorization for This Off-Label (NCCN-Supported) Drug

Prior authorization (PA) is Humana's gatekeeping process to confirm that a drug is clinically appropriate before they agree to pay for it. For off-label oncology drugs — even those with strong NCCN Compendium support — PA is almost universally required. The initial denial here is not necessarily a clinical judgment that the drug is wrong for you; it is a process requirement that has not yet been satisfied. However, if the PA was submitted and denied, you now have a clinical denial that is fully appealable.

## Why This Is Appealable

When a PA denial cites inadequate documentation or clinical criteria not met, the denial can be overturned by submitting the correct documentation. If Humana denied the PA on clinical grounds despite an applicable NCCN Compendium listing, the denial is inconsistent with standard coverage frameworks and should be challenged directly.

## Federal Appeal Framework

• PA resubmission vs. formal appeal: If the PA was never properly submitted, work with your prescriber to resubmit with complete documentation first. If Humana denied a completed PA, file a formal internal appeal within the timeframe on the EOB.
• External review (ACA §2719): A denied PA for a medically necessary drug qualifies for external review. Standard window is approximately four months from final internal denial; expedited review (72-hour decision) is available if delay would jeopardize your health.
• ERISA §503 (employer plans): Full-and-fair review rights apply; request the complete clinical criteria used.

## Documentation to Gather

1. Complete PA package — confirm your prescriber submitted all required forms; request a copy of what was actually submitted. 2. Diagnosis documentation — pathology, imaging, molecular markers establishing the specific indication. 3. Prior treatment history — dated records of prior therapies with outcomes, if step-therapy or prior-failure is a PA requirement. 4. NCCN compendium printout — the applicable NCCN listing for this drug/indication. 5. Prescriber medical-necessity letter — a detailed letter specifically addressing each criterion in Humana's PA policy. 6. Humana's PA criteria — obtain the published clinical criteria Humana applies to this drug; ensure every item is addressed.

## Criteria-Mapping Structure

Obtain Humana's PA clinical criteria for this drug class or drug. List each criterion as a row. In the adjacent column, cite the specific chart document that satisfies it — with date and source. This table becomes the backbone of the PA appeal submission.